Newborn screening for sickle cell disease in Mozambique
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study tests a new program to screen all newborns in Mozambique for sickle cell disease. It aims to find affected babies early so they can get proper care and live healthier lives.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be under 6 months old and receive care at a participating health center in Mozambique.
- The trial is for babies who have screened positive for sickle cell disease (or had unclear results), and also for healthy babies as a comparison group.
- Babies who have had a blood transfusion in the last 3 months are not able to take part.
- For healthy control babies: they must have tested negative for sickle cell disease or have sickle cell trait (carrier).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new computer system to help hospitals quickly identify babies with sickle cell disease (an inherited blood disorder) right after birth or at early health visits. Finding sickle cell disease early helps prevent serious health problems and saves lives.
This study tests a new way to track and share information about newborn sickle cell disease screening at health centers in your community. If your baby is under 1 year old, they may be able to get screened for sickle cell disease, a blood disorder, as part of this project.
This trial tests a “biochip” device using samples from people with sickle cell disease. If it works, it may help doctors study sickle cell biology more accurately using patient samples.
This study collects blood samples from up to 1 million people in Uganda to learn more about sickle cell disease. It helps doctors understand how common it is and how to better care for those affected.
This study helps connect adults with sickle cell disease who haven't seen a specialist in over a year back into care. It tests a program designed to make it easier to get regular medical support and improve your health.
This study collects feedback through surveys, interviews, and focus groups from people affected by sickle cell disease. Your input helps the research team improve how genomic and gene-therapy information and needs are understood for patients and caregivers.
Hear when a new Sickle Cell Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.